Predictive value of the Kuijer score for bleeding and other adverse in-hospital events in patients with venous thromboembolism

被引:7
作者
Keller, Karsten [1 ,2 ,3 ]
Muenzel, Thomas [1 ,4 ]
Hobohm, Lukas [1 ,2 ]
Ostad, Mir A. [1 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Dept Cardiol, Cardiol 1, Langenbeckstr 1, D-55131 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis CTH, Mainz, Germany
[3] Univ Hosp Heidelberg, Dept Sports Med, Med Clin 7, Heidelberg, Germany
[4] German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, Mainz, Germany
关键词
Venous thromboembolism; Mortality; Pulmonary embolism; Deep venous thrombosis; Bleeding; ACUTE PULMONARY-EMBOLISM; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; RISK SCORES; TASK-FORCE; ANTICOAGULATION; GUIDELINES; MANAGEMENT; VALIDATION; DIAGNOSIS;
D O I
10.1016/j.ijcard.2020.11.075
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Venous thromboembolism (VTE) constitute a major global burden of disease. Current international guidelines recommend treatment with anticoagulant therapy after VTE for a duration of at least 3 months. Since anticoagulation also imposes an increased risk for bleeding events, the individual risk has to be evaluated to determine adequate treatment plans. Methods: The nationwide German inpatient sample of the years 2005-2017 was used for this analysis. Hospitalized VTE patients were stratified according to Kuijer risk class and the performance of the Kuijer score was evaluated to predict adverse in-hospital events. Results: Overall, 1.204,895 VTE patients were treated between 2005 and 2017 in Germany and were included in the present study (839.143 patients had deep venous thrombosis and/or thrombophlebitis and 669,881 patients pulmonary embolism). According to Kuijer risk class stratification, in total, 176,723 (14.7%) of the hospitalized VIE patients were classified as low risk, 914.964 (75.9%) as intermediate risk and 113208 (9.4%) as high risk. A higher Kuijer risk class was predictive for in-hospital death (odds ratio [OR] 1.99 [95% confidence interval (CI) 1.96-2.02], P < 0.001), major adverse cardiovascular and cerebrovascular events (MACCE, OR 1.90 [95%CI 1.87-1.93], P < 0.001), intracerebral bleeding (OR 128 [95%CI 1.14-1.44], P <0.001), gastrointestinal bleeding (OR 1.56 [95%CI 1.48-1.64]. P < 0.001) as well as necessity of transfusion of blood constituents (OR 2.94 [95% CI 2.88-3.00], P < 0.001) independently of important comorbidities. Conclusions: The Kuijer score is an important risk stratification tool to predict individual risk regarding in-hospital outcomes comprising major bleeding events such as intracerebral bleeding and necessity of transfusion of blood constituents, but also in-hospital mortality and MACCE in VTE patients. (C) 2020 Elsevier B.V. All tights reserved.
引用
收藏
页码:179 / 184
页数:6
相关论文
共 36 条
  • [1] Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism
    Antonio Nieto, Jose
    Solano, Rosario
    Trapero Iglesias, Natacha
    Ruiz-Gimenez, Nuria
    Fernandez-Capitan, Carmen
    Valero, Beatriz
    Tiberio, Gregorio
    Bura-Riviere, Alessandra
    Monreal, Manuel
    [J]. THROMBOSIS RESEARCH, 2013, 132 (02) : 175 - 179
  • [2] Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
    Beyth, RJ
    Quinn, LM
    Landefeld, CS
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 105 (02) : 91 - 99
  • [3] Risk Stratification for Bleeding Complications in Patients With Venous Thromboembolism: Application of the HAS-BLED Bleeding Score During the First 6 Months of Anticoagulant Treatment
    Brown, Joshua D.
    Goodin, Amie J.
    Lip, Gregory Y. H.
    Adams, Val R.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (06):
  • [4] Association Between Postoperative Troponin Levels and 30-Day Mortality Among Patients Undergoing Noncardiac Surgery
    Devereaux, P. J.
    Chan, Matthew T. V.
    Alonso-Coello, Pablo
    Walsh, Michael
    Berwanger, Otavio
    Villar, Juan Carlos
    Wang, C. Y.
    Garutti, R. Ignacio
    Jacka, Michael J.
    Sigamani, Alben
    Srinathan, Sadeesh
    Biccard, Bruce M.
    Chow, Clara K.
    Abraham, Valsa
    Tiboni, Maria
    Pettit, Shirley
    Szczeklik, Wojciech
    Buse, Giovanna Lurati
    Botto, Fernando
    Guyatt, Gordon
    Heels-Ansdell, Diane
    Sessler, Daniel I.
    Thorlund, Kristian
    Garg, Amit X.
    Mrkobrada, Marko
    Thomas, Sabu
    Rodseth, Reitze N.
    Pearse, Rupert M.
    Thabane, Lehana
    McQueen, Matthew J.
    VanHelder, Tomas
    Bhandari, Mohit
    Bosch, Jackie
    Kurz, Andrea
    Polanczyk, Carisi
    Malaga, German
    Nagele, Peter
    Le Manach, Yannick
    Leuwer, Martin
    Yusuf, Salim
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (21): : 2295 - 2304
  • [5] Deep vein thrombosis and pulmonary embolism
    Di Nisio, Marcello
    van Es, Nick
    Bueller, Harry R.
    [J]. LANCET, 2016, 388 (10063) : 3060 - 3073
  • [6] A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study
    Fang, Margaret C.
    Go, Alan S.
    Chang, Yuchiao
    Borowsky, Leila H.
    Pomernacki, Niela K.
    Udaltsova, Natalia
    Singer, Daniel E.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (04) : 395 - 401
  • [7] Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    Gage, BF
    Yan, Y
    Milligan, PE
    Waterman, AD
    Culverhouse, R
    Rich, MW
    Radford, MJ
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (03) : 713 - 719
  • [8] Comparison of risk assessment strategies for not-high-risk pulmonary embolism
    Hobohm, Lukas
    Hellenkamp, Kristian
    Hasenfuss, Gerd
    Muenzel, Thomas
    Konstantinides, Stavros
    Lankeit, Mareike
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (04) : 1170 - 1178
  • [9] Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism
    Kearon, C
    Ginsberg, JS
    Kovacs, MJ
    Anderson, DR
    Wells, P
    Julian, JA
    MacKinnon, B
    Weitz, JI
    Crowther, MA
    Dolan, S
    Turpie, AG
    Geerts, W
    Solymoss, S
    van Nguyen, P
    Demers, C
    Kahn, SR
    Kassis, J
    Rodger, M
    Hambleton, J
    Gent, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (07) : 631 - 639
  • [10] Antithrombotic Therapy for VTE Disease CHEST Guideline and Expert Panel Report
    Kearon, Clive
    Akl, Elie A.
    Ornelas, Joseph
    Blaivas, Allen
    Jimenez, David
    Bounameaux, Henri
    Huisman, Menno
    King, Christopher S.
    Morris, Timothy A.
    Sood, Namita
    Stevens, Scott M.
    Vintch, Janine R. E.
    Wells, Philip
    Woller, Scott C.
    Moores, Lisa
    [J]. CHEST, 2016, 149 (02) : 315 - 352